Synairgen
  • About us
    • Synairgen’s Directors
    • Founders
    • Research Capabilities
  • Our BioBank Platform Technology
  • Our Drug Programmes
    • IFN-β for the treatment of COVID-19
    • IFN-β (SNG001) in COPD
    • LOXL2 inhibitors in Fibrotic Disease
    • Collaboration Opportunities
    • Managed Access Program
  • News
    • Press Releases
    • TR-1/Options Press Releases
  • Contact us
    • Employment Opportunities
Select Page

Posting of Annual Report and Notice of AGM

by wpengine | May 17, 2018 | Uncategorized | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Dummy news post 2018
  • Posting of Annual Report and Notice of AGM

Recent Comments

    Archives

    • September 2018
    • May 2018

    Categories

    • Interim statements
    • Presentations
    • Press release 2015
    • Press release 2016
    • Press release 2017
    • Press release 2018
    • Press release 2019
    • Press release 2020
    • Press release pre-2015
    • Regulatory Press Release 2017
    • Regulatory Press Release 2018
    • Regulatory Press Release 2019
    • Regulatory Press Release 2020
    • Report and accounts
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Investors

    • Stock feed
    • Presentations
    • Press Releases
    • TR-1/Options Press Releases
    • Financials
    • Analysts
    • Major shareholders
    • AIM Rule 26
    • Corporate Governance Statement
    • Advisers
    • Glossary
    • Links